clinical environment as a medical representative dealing with medical institutions and physicians or as a study coordinator.... We understand what clinical study sites need and our overall mission is to support sites in stronger study delivery...
clinical environment as a medical representative dealing with medical institutions and physicians or as a study coordinator.... We understand what clinical study sites need and our overall mission is to support sites in stronger study delivery...
Hobson Prior is seeking a ClinicalResearchCoordinator for an oncology study in Porto Alegre, Brazil. This role... involves supporting clinicalresearch activities on-site for a 6-month project, working approximately 20 hours per week...
years of relevant clinicalresearch experience. Excellent written and verbal communication skills, good command of English..., Colombia and Peru! #LI-Remote #LI-NRJ IQVIA is a leading global provider of clinicalresearch services, commercial insights...
, come and join us - IQVIA are looking ClinicalResearchCoordinator. This role has an immediate start working 20 hours a week for a period...Are you looking for an opportunity in ClinicalResearch? Do you want to work for an industry leading company...
Coordinators, you will gain valuable hands on experience to enable you to develop a career in clinicalresearch. Responsibilities... applications in English. Medpace Overview : Medpace is a full-service clinical contract research organization (CRO). We provide...
Coordinators, you will gain valuable hands on experience to enable you to develop a career in clinicalresearch. Responsibilities... applications in English. Medpace Overview Medpace is a full-service clinical contract research organization (CRO). We provide...
Enviro Infra Engineers IPO opens for subscription on November 22, aiming to raise funds for working capital and growth. The company specialises in water treatment projects and has built 28 plants since 2017. The IPO price band is set between ₹140 to ₹148 per share. Continue Reading »
Abhijit Bhave, Managing Director and CEO, Equirus Wealth believes a 5-10% correction from current levels might be a fair expectation for stabilization. However, a strong earnings report card in December quarter is what might bring some sense of relief in the markets, he noted. Continue Reading »
Amid market corrections, 14 Nifty 500 stocks saw gains of 10% to 38%. Syrma SGS Technology led with a 37.5% increase, while Deepak Fertilisers rose 22%. ITI and Kirloskar Brothers also recorded significant gains following positive Q2 results. Continue Reading »
The Indian market faces challenges from rising dollar index and foreign investor outflows. While November shows a 3% decline, analysts predict a recovery in FY25 supported by government spending and consumer demand. Investors should monitor global developments and focus on a diversified portfolio. Continue Reading »
Stock Check: Marico share price dropped 20% from its peak, despite a 20.27% increase in Q2FY25 net profit. Analysts downgraded the stock to 'Accumulate' with a target of ₹678, citing rising costs and slow urban consumption recovery due to high food inflation. Continue Reading »
The NTPC Green Energy IPO, targeting ₹10,000 crore, has seen robust interest, particularly from retail investors. The first day marked a 33% subscription rate, with retail oversubscribing 1.33 times. The offering aims to fund renewable energy projects and reduce existing debts. Continue Reading »
Indian equities faced significant selloff following disappointing September quarter earnings, with mid and small-cap stocks hit hardest. Brokerage firms have lowered earnings estimates, citing reduced government expenditure and slowing urban consumption. Continue Reading »